Gluco Control – Reviews, Ingredients, Study Findings and Where to Buy
Dr. John Halbert's Gluco Control journey began with a personal mission—witnessing his own mother's struggle with type 2 diabetes and the harsh realities of conventional treatments. Over an 11-year career, Dr. Halbert has become a trusted authority in the diabetes community, sharing his insights and inspiring thousands with his bestselling book, Diabetes Freedom. His innovative 'Halbert Protocol' emphasizes a holistic approach that combines traditional wisdom with modern scientific understanding. Gluco Control is the culmination of his extensive research and clinical experience, designed to support the body's natural ability to regulate blood sugar levels while addressing underlying factors—such as impaired insulin sensitivity and gut imbalance—that conventional medications often overlook.
The Science Behind Gluco Control
Gluco Control also addresses the role of gut microbiota in type 2 diabetes by focusing on the impact of Prevotella bacteria. Studies have revealed that individuals with type 2 diabetes frequently exhibit elevated levels of certain gut bacteria, such as Prevotella, compared to healthy individuals. Research involving identical twin studies indicates that differences in gut microbiota composition may help explain why one twin develops diabetes while the other does not. Evidence suggests that an excess of Prevotella can form a physical barrier that hinders insulin from reaching cells, thereby contributing to hyperglycemia and increased insulin resistance. Gluco Control's carefully selected natural ingredients are intended to help restore a balanced gut microbiota, potentially reducing the impact of bacterial overgrowth on blood sugar regulation and supporting optimal insulin function.
Gluco Control also considers how modern lifestyle factors, such as disrupted sleep and high stress levels, affect insulin function through alterations in gut microbiota. Poor sleep quality has been associated with an increased production of harmful bacteria, which may compromise insulin sensitivity and impair blood sugar control. Studies indicate that even moderate improvements in sleep can positively influence the gut environment and overall metabolic health. By promoting a healthier gut microbiota, the natural ingredients in Gluco Control may help mitigate the adverse effects of sleep disruption on insulin function. This insight reinforces the rationale behind Gluco Control's formulation and underscores the importance of addressing lifestyle factors as part of a holistic approach to managing type 2 diabetes and supporting healthy blood sugar levels. More details on how Gluco Control works and its availability can be found on the official website here.
The Secret Discovery Behind Gluco Control: EGCG and the Power of Jima Sylvester
Gluco Control's development was marked by a pivotal discovery—the identification of epigallocatechin gallate (EGCG), a potent natural compound, and its extraction from an Oriental herb known as Jima Sylvester. This breakthrough provided the scientific foundation for a formulation aimed at supporting metabolic health using nature's own remedies. Research into EGCG has shown its powerful antioxidant and metabolic regulatory properties, which are believed to help enhance insulin function and support overall blood sugar regulation. This discovery is a key element behind Gluco Control's approach to natural diabetes support.
The Hidden Gem in Banana Peels and Oriental Herbs: The Foundation of Gluco Control
Gluco Control's formulation is built upon extensive research by Dr. John Halbert, who explored various natural sources traditionally used in medicine to regulate blood sugar. In his investigations, proteins found in banana peels and other time-honored Oriental herbs emerged as promising candidates for counteracting the detrimental effects of gut bacteria on insulin function. These natural components, long valued in cultural healing traditions, have now been rediscovered and integrated into Gluco Control's formula. By combining ancient wisdom with modern scientific insights, Gluco Control aims to support healthy blood sugar levels naturally.
Revolutionary Extraction of Concentrated EGCG: The Secret Behind Gluco Control's Effectiveness
Gluco Control employs a revolutionary extraction process to obtain a highly concentrated form of EGCG from Jima Sylvester. In traditional Japanese medicine, Jima Sylvester is revered as 'the sugar destroyer' for its role in supporting metabolic health. Researchers have found that when EGCG is extracted at high concentrations, it can help dissolve the protective barrier formed by certain gut bacteria, which may otherwise interfere with insulin's ability to access cells. This concentrated EGCG extract is central to Gluco Control's mission of enhancing the body's natural insulin function and promoting a balanced glucose metabolism. By harnessing this potent natural compound, Gluco Control offers a scientifically grounded, nature-based approach to managing blood sugar levels.
Transforming Diabetes Management with Gluco Control
Gluco Control is designed to be an integral part of a daily routine that supports overall metabolic health. Its formulation, based on the principles of the Halbert Protocol, offers a new way of approaching diabetes management—one that is natural, supportive, and firmly grounded in scientific research on its individual ingredients. Gluco Control provides a holistic alternative to conventional medications by focusing on natural support to help maintain healthy blood sugar levels and improve insulin sensitivity.
From Laboratory Breakthrough to Life Changing Results: The Gluco Control Journey
The journey of Gluco Control began in the research laboratories, where scientists and healthcare professionals worked tirelessly to combine the best of traditional remedies with modern extraction techniques. Although the complete product has not undergone independent clinical trials, numerous studies on its individual components have demonstrated promising effects on blood sugar regulation and metabolic function. Early adopters of this natural diabetes management supplement have reported anecdotal improvements such as stabilized blood sugar readings, increased energy levels, and a renewed sense of well-being. These life-changing results, shared by users inspired by the Halbert Protocol, underscore the potential of Gluco Control as part of a comprehensive strategy for supporting healthy glucose metabolism.
Demonstrating the Mechanism: How Gluco Control Dissolves the Bacterial Barrier
One of the most compelling aspects of Gluco Control is its proposed mechanism of action. Gluco Control operates on the principle that insulin acts as a key to unlock cells for glucose utilization as energy. In individuals with type 2 diabetes, excessive production of gut bacteria—particularly during sleep—can create a physical barrier that prevents insulin from reaching its target cells. The concentrated EGCG found in Gluco Control is believed to help dissolve this bacterial barrier, thereby enabling insulin to function more effectively. Although this mechanism is based on published research on EGCG and related natural compounds rather than product-specific trials, it offers an intriguing explanation for how natural ingredients may support improved glucose metabolism over time. For more insights on Gluco Control's unique approach and to explore its scientific foundations, you can visit the official website where extensive details are provided.
Gluco Control's Premium, Natural Ingredients for Optimal Blood Sugar BalanceGluco Control is formulated with a synergistic blend of natural ingredients that work together to support metabolic health, enhance insulin sensitivity, and promote balanced blood sugar levels. Each component in this natural supplement for diabetes management has been carefully selected based on extensive research, ensuring that Gluco Control provides a holistic approach to blood sugar regulation.
Gymnema Sylvestre in Gluco Control: Suppressing Sugar Cravings and Enhancing Insulin Production
Gymnema Sylvestre, a traditional herb used in Ayurvedic medicine for centuries, plays a vital role in Gluco Control. Research has shown that Gymnema Sylvestre can help suppress sugar cravings by blocking sweet receptors on the tongue, thereby reducing the desire for sugary foods. In addition, this herb has been found to enhance insulin secretion, supporting the body's natural production of insulin. By integrating Gymnema Sylvestre, Gluco Control offers a natural way to promote stable blood sugar levels and support metabolic balance.
Grape Seed Extract in Gluco Control: Promoting Cardiovascular Health and Insulin Sensitivity
Grape seed extract is renowned for its high antioxidant content and its benefits in promoting cardiovascular health, both of which are critical in diabetes management. Studies indicate that grape seed extract can reduce oxidative stress and inflammation—factors that are closely linked to insulin resistance. In Gluco Control, grape seed extract helps improve insulin sensitivity and supports healthy blood vessels, contributing to an optimal environment for glucose metabolism. This natural ingredient complements the overall formulation, enhancing the supplement's effectiveness in supporting balanced blood sugar levels.
Green Tea Extract in Gluco Control: Boosting Metabolism and Regulating Appetite
Green tea extract, particularly its rich catechin content, has been extensively studied for its metabolic benefits. Research suggests that green tea extract can boost the metabolic rate, enhance fat oxidation, and regulate appetite by influencing satiety hormones like leptin. These effects are crucial for weight management, which is a key aspect of maintaining healthy blood sugar levels. In Gluco Control, green tea extract is incorporated to promote a more active metabolism and to help reduce the likelihood of overeating, thereby supporting a natural approach to diabetes management.
African Mango Extract in Gluco Control: Supporting Natural Weight Management and Glucose Balance
Studies have demonstrated that African mango extract can increase the production of enzymes and molecules that help convert excess calories into energy instead of storing them as fat. Given the close relationship between excess weight and insulin resistance, African mango extract is a valuable addition to Gluco Control's formulation. It aids in natural weight management and helps maintain balanced blood sugar levels, providing a comprehensive approach to supporting overall metabolic function. Learn more about the formula and its benefits by visiting the official Gluco Control website here.
Gluco Control Reviews and Success Stories
The extensive research on each component provides a strong scientific rationale for Gluco Control as a natural supplement for managing type 2 diabetes and supporting healthy blood sugar levels. In addition to this scientific foundation, numerous real-life experiences demonstrate how Gluco Control has the potential to transform lives by improving metabolic health and promoting balanced glucose regulation. for 4 seconds
Extensive research on each component provides a robust scientific rationale for using Gluco Control as a natural supplement to manage type 2 diabetes and support healthy blood sugar levels. Alongside this scientific foundation, numerous real-life experiences demonstrate that Gluco Control has the potential to transform lives by improving metabolic health and promoting balanced glucose regulation.
Real-Life Case Studies: How Gluco Control Transformed Lives from Uncontrolled Diabetes to Renewed Vitality
Gluco Control has been incorporated into holistic, natural supplement routines by many individuals seeking alternative approaches to diabetes management. For example, one case involved a 52-year-old mother whose struggle with unstable blood sugar and chronic fatigue gradually improved after she began using natural supplements containing the same high-quality ingredients found in Gluco Control. In another instance, a 63-year-old retiree experienced a marked reduction in his dependency on insulin injections after adopting a comprehensive, natural regimen inspired by Gluco Control's formulation. These real-life case studies underscore the potential of Gluco Control as an integral part of a broader strategy to manage type 2 diabetes and restore vitality.
Gluco Control Reviews: How Gluco Control Restored Hope and Changed Lives
Gluco Control is further validated by reviews from individuals who have embraced natural methods for diabetes support. Many users have described their experiences with Gluco Control as life-changing, reporting not only enhanced blood sugar control but also noticeable improvements in energy, mood, and overall quality of life. These testimonials provide compelling anecdotal evidence that Gluco Control can empower users to regain control over their health, offering hope and inspiring those facing similar challenges to consider natural, ingredient-based support for their diabetes management journey.
For those curious about how Gluco Control can fit into their lifestyle, more details and real user experiences are available on the official website.
Gluco Control: Safety and Quality
Ensuring the safety and quality of dietary supplements is essential, particularly when they are intended to support health conditions such as type 2 diabetes. Gluco Control is produced in FDA-approved facilities under stringent quality control standards, assuring customers of its purity and consistency.
Gluco Control's 100% Natural, Non-GMO, and Side Effect-Free Formula
Gluco Control is made exclusively from natural ingredients and is non-GMO, lactose-free, and gluten-free. Each component is carefully selected based on its traditional use and is supported by scientific research on its individual benefits for metabolic health. Importantly, Gluco Control is formulated without synthetic additives or harmful chemicals. Although the complete Gluco Control product has not been the subject of product-specific clinical trials, the safety profiles of its individual ingredients have been well established in numerous independent studies. This natural, side effect-free formulation is designed to support the body's metabolic processes and insulin function without the risks commonly associated with conventional medications.
Rigorous Quality Control and State-of-the-Art Manufacturing Standards for Gluco Control
The manufacturing facilities adhere to rigorous FDA-approved guidelines and use state-of-the-art technology to ensure the consistency and potency of every batch of Gluco Control. Advanced analytical techniques—such as high-performance liquid chromatography and spectroscopy—are employed to verify that each ingredient meets strict quality standards. This commitment to excellence guarantees that Gluco Control is not only effective in supporting healthy blood sugar levels but also safe for long-term use as part of an overall health routine.
Beyond Conventional Treatments: The Gluco Control Advantage
Traditional diabetes treatments, while effective for some individuals, often carry unwanted side effects and primarily focus on managing symptoms rather than addressing the underlying causes of type 2 diabetes. Gluco Control offers a distinct advantage by harnessing the power of natural ingredients to support the body's inherent mechanisms for maintaining healthy blood sugar levels. This innovative approach positions Gluco Control as a promising natural supplement for holistic diabetes management and long-term blood sugar control.
Why Traditional Medications Fall Short: The Gluco Control Advantage in Addressing the Root Cause
Conventional treatments such as metformin and insulin injections are engineered to lower blood sugar levels quickly, yet they frequently fail to tackle the deeper, systemic issues that contribute to type 2 diabetes—particularly imbalances in gut microbiota. These medications may provide temporary relief but often come with significant side effects and can lose effectiveness over time. In contrast, Gluco Control's natural formulation is designed to work in harmony with the body. It supports underlying metabolic processes such as insulin sensitivity and gut health, offering a more holistic and sustainable approach to diabetes management. By addressing these core issues, Gluco Control distinguishes itself as a natural solution that aims to restore balance rather than merely suppressing symptoms.
How Gluco Control Targets the Hidden Culprit Behind Type 2 Diabetes
The key to Gluco Control's potential effectiveness lies in its ability to target one of the hidden culprits in type 2 diabetes: the overproduction of specific gut bacteria during sleep that interfere with insulin function. While conventional therapies tend to overlook this critical factor, the ingredients in Gluco Control have been carefully selected for their potential to modulate the gut microbiome. By promoting a healthier balance of gut bacteria, Gluco Control may help reduce insulin resistance and foster a more stable blood sugar profile. This targeted approach not only sets Gluco Control apart from other supplements on the market but also underscores its promise as a natural, science-based strategy for addressing the root causes of type 2 diabetes.
Exclusive Offers and Ordering Information for Gluco Control
To celebrate Gluco Control's launch, exclusive introductory pricing and bundled package offers are now available for a limited time.
Gluco Control Exclusive Offers: Special Introductory Pricing, Bundle Options, and Free Shipping Details
For a limited time, Gluco Control is available in several convenient packages designed to meet different needs:
6-Bottle Kit (180-Day Supply):
Price: Only $39 per bottle
Savings: Save up to $780 compared to individual purchases
Bonus: Includes free US shipping and a 180-day money-back guarantee
3-Bottle Kit (90-Day Supply):
Price: $49 per bottle, with free shipping
Ideal For: Those who wish to try the product before committing long-term
1-Bottle Option (30-Day Supply):
Price: $69 per bottle
Great For: New users looking to experience the potential benefits on a shorter-term basis
How to Secure Your Gluco Control Supply Through Our Secure Online Portal
Ordering Gluco Control is simple and secure:
Visit Our Official Website:Navigate to the official website to view detailed product information and current offers.
Select Your Preferred Package:Choose the package that best suits your needs—whether it's a 30-day, 90-day, or 180-day supply.
Complete the Secure Checkout:Fill in your personal details, shipping address, and payment information using our advanced secure payment gateway. All transactions are encrypted to protect your privacy.
Enjoy Free Shipping:All orders during the promotional period include free shipping within the United States.
Begin Your Journey:Start incorporating Gluco Control into your nightly routine and support your body's natural ability to regulate blood sugar.
The Gluco Control Guarantee: 180-Day Risk-Free Trial
Gluco Control is committed to providing a risk-free trial for individuals seeking natural diabetes management. The company behind Gluco Control, says there is a strong belief in the supplement's potential to support healthy blood sugar levels through its innovative natural formulation. Gluco Control is offered with an unconditional 180-day money-back guarantee, ensuring that users can experience this natural diabetes support solution without any financial risk.
Our Unconditional 180 Day Money Back Guarantee for Gluco Control Explained
If a user is not completely satisfied with their experience with Gluco Control within 180 days of purchase, they can return any or all of their Gluco Control bottles—full or empty—for a full refund. This unconditional 180-day money-back guarantee for Gluco Control means that customers only pay if Gluco Control helps support healthier blood sugar levels and improves overall metabolic health. This guarantee reflects its commitment to quality and its confidence in the natural formulation of Gluco Control as an effective, long-term supplement for managing type 2 diabetes.
Customer Assurance: Pay Only if Gluco Control Conquers Your Diabetes
For individuals who have struggled with type 2 diabetes for years, the risk-free trial for Gluco Control removes any hesitation about trying a natural alternative. With the Gluco Control 180-day money-back guarantee, users have the opportunity to integrate Gluco Control into their daily routine and experience its benefits over an extended period. If Gluco Control does not help achieve more stable blood sugar levels and an overall improvement in quality of life, every penny will be refunded—no questions asked. This customer assurance underscores the confidence in Gluco Control's ability to support natural diabetes management, allowing users to embark on their health journey without risk.
Gluco Control Final ThoughtsGluco Control offers a promising new path to better health and balanced blood sugar levels by embracing natural solutions that work in harmony with the body. Gluco Control represents a fresh start—a chance to take control of health, reduce the impact of type 2 diabetes, and reclaim the joy of a vibrant, active life. Gluco Control is designed to support the body's natural metabolic processes through a simple nightly ritual that harnesses the benefits of premium, natural ingredients. This approach helps support insulin function, reduces sugar cravings, and promotes overall well-being, aligning with Dr. John Halbert's vision of a natural tool that empowers individuals to manage diabetes and live a more fulfilling life.
Empowering You to Take Control of Your Health with Gluco Control and Reclaim Your Life
Imagine waking up each day with more stable blood sugar levels, increased energy, and the freedom to enjoy life's simple pleasures without the constant worry of diabetes-related complications. Gluco Control is formulated to support a natural metabolic balance by working synergistically with the body's own processes. With Gluco Control, individuals can experience improved insulin sensitivity and better glucose regulation through a straightforward, natural regimen. The philosophy behind Gluco Control is rooted in providing a holistic approach to diabetes management—one that not only addresses the symptoms but also targets the underlying factors that conventional treatments often overlook.
Join the Gluco Control Movement Toward a Brighter, Diabetes-Free Future
Gluco Control invites everyone to join a growing movement toward a healthier, diabetes-free future. Today is the day to embrace a natural, holistic approach to blood sugar management. With exclusive offers available through official website, there has never been a better time to try Gluco Control. Whether choosing the best-value 6-bottle kit for a 180-day supply, the 3-bottle kit for a 90-day supply, or the introductory 1-bottle option for a 30-day trial, each package is designed to empower individuals to take charge of their health. Gluco Control's 180-day risk-free money-back guarantee means there is nothing to lose and everything to gain. By choosing Gluco Control, users join a community of individuals dedicated to natural diabetes management—reclaiming their lives from the burdens of type 2 diabetes and stepping into a future filled with renewed vitality and lasting well-being.
Media Contact
Media Contact: John HalbertEmail: media@goglucocontrol.comAddress: 8575 Somerset Dr., Ste A Largo, FL 33773 USA
Source: https://thrivewellplace.com/gluco-control-reviews-ingredients-study-findings-and-where-to-buy/
About Gluco Control
Gluco Control is a revolutionary natural dietary supplement developed to support healthy blood sugar levels and improve insulin function. This innovative supplement is designed specifically for individuals seeking a holistic, nature-based approach to diabetes management. Although Gluco Control as a complete product has not been evaluated in its own clinical trials, its formulation is built upon a robust body of scientific research on its individual ingredients.
Gluco Control harnesses the power of well-researched natural components such as Gymnema Sylvestre, grape seed extract, green tea extract, African mango extract, and a concentrated extract of EGCG from Jima Sylvester. Gymnema Sylvestre is renowned for its ability to suppress sugar cravings and support natural insulin secretion, while grape seed extract is celebrated for its potent antioxidant properties and its role in promoting cardiovascular health and insulin sensitivity. Green tea extract, rich in catechins, supports an active metabolism and helps regulate appetite, and African mango extract contributes to natural weight management and balanced glucose levels. The concentrated EGCG from Jima Sylvester, a key ingredient in Gluco Control, has been widely studied for its capacity to enhance insulin sensitivity and support metabolic balance.
Manufactured in FDA-approved facilities under stringent quality control standards, Gluco Control is 100% natural, non-GMO, lactose-free, and gluten-free. Advanced manufacturing processes and rigorous analytical testing ensure that every batch of Gluco Control maintains consistent potency and purity. This commitment to excellence underscores Gluco Control's mission to offer a safe, natural, and sustainable supplement that supports overall metabolic health and blood sugar regulation.
By combining traditional wisdom with modern scientific insights, Gluco Control provides a promising alternative for managing type 2 diabetes naturally. Its formulation not only targets the symptoms of high blood sugar but also addresses underlying metabolic imbalances. Gluco Control empowers individuals to take control of their health, reclaim their quality of life, and experience the benefits of a natural dietary supplement designed to promote balanced blood sugar levels and overall well-being.
Frequently Asked Questions About Gluco Control
To help individuals make an informed decision about this natural supplement for blood sugar management, the following expanded FAQ section provides detailed answers to common questions regarding Gluco Control.
How Should I Take Gluco Control?Gluco Control is designed for ease of use as a liquid supplement. It is recommended to take 2 drops daily, preferably before bedtime, to support the body's natural metabolic processes during sleep. This formulation is intended for sublingual absorption, which allows the active ingredients in Gluco Control to be quickly delivered into the system for optimal support in maintaining healthy blood sugar levels.
How Soon Can I Expect to See Results from Using Gluco Control?While individual experiences may vary, many users of Gluco Control report improvements in blood sugar stability and overall energy within 4 to 6 weeks of consistent use. The natural ingredients in Gluco Control work gradually to enhance insulin sensitivity and promote balanced glucose metabolism, making it a holistic approach to long-term diabetes management.
Can I Use Gluco Control Alongside My Current Diabetes Medications?Gluco Control is intended to complement existing treatment plans as a natural supplement for blood sugar regulation. Many users have found that incorporating Gluco Control into their daily routine alongside prescribed medications supports improved overall metabolic function. However, it is important for individuals to consult their healthcare provider before adding any new supplement—especially if they are currently taking diabetes medications—to ensure that Gluco Control fits safely into their treatment regimen.
Are There Any Known Side Effects Associated with Gluco Control?Gluco Control is formulated using 100% natural ingredients, each of which has been extensively studied for safety. Although the complete product has not undergone product-specific clinical trials, the safety profiles of its individual components—such as Gymnema Sylvestre, grape seed extract, green tea extract, and African mango extract—are well documented. For most users, Gluco Control is side effect-free. Nonetheless, individuals with pre-existing conditions or concerns are encouraged to consult their healthcare provider before use.
Is Gluco Control Safe for Long-Term Use?Gluco Control is manufactured in FDA-approved facilities under stringent quality control standards, ensuring a consistent, high-quality, and natural supplement. Many users incorporate Gluco Control as part of their daily health routine over the long term. The natural formulation, free from synthetic additives and harmful chemicals, is designed to support metabolic processes and blood sugar regulation safely over time. As always, individuals should consult with a healthcare professional to determine if long-term use is appropriate for their specific health needs.
What Makes Gluco Control Different from Other Natural Supplements for Blood Sugar Management?Gluco Control stands out because its formulation is based on a robust body of scientific research on its individual ingredients. By combining traditional wisdom with modern scientific insights, Gluco Control targets underlying factors such as impaired insulin sensitivity and gut microbiota imbalances—areas that conventional treatments often overlook. This holistic, nature-based approach differentiates Gluco Control from many other supplements, offering a comprehensive strategy to support healthy blood sugar levels and overall metabolic health.
Where Is Gluco Control Manufactured and How Is Its Quality Ensured?Gluco Control is produced in an FDA-approved facility under rigorous quality control standards. The manufacturing process utilizes state-of-the-art technology, including advanced analytical techniques such as high-performance liquid chromatography and spectroscopy, to ensure the purity, potency, and consistency of every batch. This commitment to quality ensures that Gluco Control is a safe, reliable natural supplement for supporting healthy blood sugar regulation.
How Should I Store Gluco Control?To maintain the potency and effectiveness of Gluco Control, it is recommended to store the product in a cool, dry place away from direct sunlight. Proper storage helps preserve the integrity of the natural ingredients, ensuring that each dose continues to support healthy glucose metabolism and insulin function as intended.
What Is the Refund Policy for Gluco Control?Gluco Control is backed by a 180-day risk-free money-back guarantee. If a user is not completely satisfied with the results within 180 days of purchase, they can return any or all of their Gluco Control bottles—full or empty—for a full refund. This unconditional guarantee demonstrates the confidence in Gluco Control's ability to support healthy blood sugar levels and provides a no-risk opportunity to experience the benefits of a natural approach to diabetes management.
Are There Any Dietary or Supplement Interactions with Gluco Control?Gluco Control is formulated with natural ingredients that have been traditionally used to support metabolic health. While there are no known adverse interactions with common foods or other supplements, individuals who take multiple supplements or have specific dietary concerns should consult their healthcare provider. This ensures that Gluco Control is integrated safely and effectively into an overall health regimen.
Disclaimer
The information provided in this press release is for informational purposes only and should not be considered medical advice. The statements regarding Gluco Control have not been evaluated by the Food and Drug Administration (FDA), and the product is not intended to diagnose, treat, cure, or prevent any disease.
Individual results may vary based on factors such as diet, metabolism, lifestyle, and consistency of use. Although Gluco Control's formulation includes scientifically studied ingredients—such as Gymnema Sylvestre, grape seed extract, green tea extract, African mango extract, and a concentrated extract of EGCG from Jima Sylvester—the specific combination of these ingredients has not undergone independent clinical trials as a complete product.
Before using Gluco Control or any dietary supplement, individuals are strongly advised to consult a healthcare professional, particularly if they are pregnant, nursing, have underlying medical conditions, or are taking prescription medications. Some ingredients may interact with medications or existing health conditions, making professional guidance essential.
Gluco Control is intended to complement a comprehensive approach to diabetes management that includes a balanced diet, regular exercise, and healthy lifestyle habits. While the manufacturer follows Good Manufacturing Practices (GMP) to ensure product quality and ingredient integrity, dietary supplements should not replace professional healthcare advice or prescribed medical treatments. Consumers should review the ingredient list carefully and discontinue use if any adverse reactions occur.
This press release does not include endorsements from medical institutions or research universities. References to scientific studies are provided solely to highlight the general benefits of the individual ingredients used in Gluco Control, rather than serving as direct validation of the product as a whole.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9236e83a-aaa1-43e6-8697-65e12e66bf8e
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/26854fb9-99e5-4fc6-8668-5dbb75b6cab1
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/b896e352-c01b-4bfc-8f69-c0e6783ff0cdSign in to access your portfolio

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Business Upturn
3 hours ago
- Business Upturn
Rocket Doctor's Virtually-Enabled Emergency Department Diversion Program Reduces Strain on Overwhelmed Hospitals
Virtually-enabled Emergency Department (ED) at Georgian Bay General Hospital has successfully connected over 3,000 patients with MDs,with 97.5% managed virtually and only 1% redirected to the ED. The Ontario program has saved an estimated $1.4 million by diverting 3,065 patients from the ER between June 2022 and December 2024. This is based on an average of $475 per visit, using cost data from Scarborough Health Network and Canadian Institute for Health Information . In the last 3 months across Alberta, Rocket Doctor has facilitated 12,000+ patient visits with MDs, with 98% of cases resolved virtually and <1% sent to ED. The Rocket Doctor platform combines smart patient-provider matching, branded hospital intake pages, and flexible staffing models to support hospital partners Vancouver, BC, July 31, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') and its wholly owned digital health platform and marketplace, Rocket Doctor, are providing a scalable response to Canada's emergency department crisis with a data-backed diversion program. The program uses smart triage, provider infrastructure, and AI-enabled care to safely keep appropriate patients with low-acuity healthcare concerns out of overcrowded hospitals, while getting them the comprehensive out-patient care that they need, faster. Across Canada, hospitals are facing unprecedented strain. Since 2019, emergency departments have experienced more than 1.14 million hours of closure , the equivalent of 47,500 lost days of emergency care. Ontario and Alberta have been hit especially hard, with rural ER closures and care disruptions becoming a regular occurrence. This reality has left communities with few options and patients in critical need of safe, timely alternatives. British Columbia is equally seeing regular ER closures throughout 2025, causing challenges for patients, healthcare systems and especially rural communities: BC is not Alone – Rural ER Crisis across Canada – BC Rural Health Network While in many cases a virtual-only system is not a replacement for in-person emergency care, Rocket Doctor's ED diversion program is helping to support hospitals and patients to fill a void in accessible care. The platform enables hospital systems to allow patients to self-select to reroute themselves to clinically appropriate, out-patient consultations, leveraging customized intake forms, real-time triage, and a flexible physician network, either from independent MDs on Rocket Doctor's platform, or the hospital's own staff. At Georgian Bay General Hospital in Ontario, the results speak for themselves. Between June 2022 and December 2024, more than 3,065 patients have been successfully managed through MDs on Rocket Doctor's platform, with 97% of patients treated virtually and only 1% redirected to the ER. Patients waited an average of just 20 minutes to connect with a physician. The estimated system savings totaled $1.4 million, based on an average $475 cost per diverted ER visit multiplied by the total number of patients seen. All visits were covered under OHIP, with no additional fees to patients. In Alberta, Rocket Doctor has seen similar success across its broader platform, with over 12,000 patients seen in the past 3 months alone, entirely funded by provincial health insurance. More than 98% of these visits were resolved without requiring in-person care, and less than 1% were sent to the ER. 'We see so many patients in our rural, remote and even urban communities going to ED, often when they recognize that they could be seen outside the hospital.' Said Dr. William Cherniak, CEO of Rocket Doctor. 'There has been a lot of good content from the Canadian Association of Emergency Physicians (CAEP) to recognize that we need to support patients to access healthcare where they see most appropriate. We often see patients choose an ED with low-acuity issues simply because of a lack of access to family doctors, or other accessible out-patient choices.' By leveraging smart triage and other digital tools, Rocket Doctor's ED Diversion Program and broader platform pairs patients with the right physician based on their needs, empowering physicians to order labs, imaging, make specialist referrals, or escalate care to in-person options when clinically necessary (although rare). Patients can also rebook with the same physician to ensure continuity of care, improving outcomes and reducing unnecessary visits. 'We are filling that gap by empowering physicians in a team-based cloud-enabled model of care with technological support to work at the top of their license within their clinical competencies digitally.' said Dr. Cherniak. 'We're building a system that gives patients a smarter entry point and gives physicians the tools to work independently, safely, and efficiently.' As staffing shortages and rural hospital disruptions continue to affect patients across Canada, Rocket Doctor and AI are offering hospitals and provincial systems a deployable, proven solution; one that reduces backlog, lowers system strain, and drives meaningful outcomes at scale. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine – the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact [email protected] . About Rocket Doctor Inc. Rocket Doctor is a technology-driven digital health platform and marketplace that is breaking down obstacles that limit access to quality, comprehensive and cost-effective healthcare. Our proprietary software equips doctors with the tools to run practices in virtual and hybridized in-person/virtual models of care, enabling them to provide tailored care to patients in rural and Northern communities across Canada and on Medicaid in the United States. Leveraging large language models, AI/ML and wireless medical devices, Rocket Doctor is bridging the healthcare divide, connecting patients to equitable and accessible virtual healthcare services regardless of age, location, or financial status. To learn more about Rocket Doctor's platform and services, visit (Canada) or (U.S.), or contact [email protected] . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO, AI Email: [email protected] Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Dr. Bill Cherniak, CEO, Rocket Doctor Email: [email protected] Media inquiries: [email protected] Cautionary Statement This news release contains forward-looking statements that are based on AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash


Hamilton Spectator
4 hours ago
- Hamilton Spectator
Rocket Doctor's Virtually-Enabled Emergency Department Diversion Program Reduces Strain on Overwhelmed Hospitals
Vancouver, BC, July 31, 2025 (GLOBE NEWSWIRE) — AI Inc. (CSE: TRUE, OTC: TREIF, Frankfurt: 939) ('Treatment') and its wholly owned digital health platform and marketplace, Rocket Doctor, are providing a scalable response to Canada's emergency department crisis with a data-backed diversion program. The program uses smart triage, provider infrastructure, and AI-enabled care to safely keep appropriate patients with low-acuity healthcare concerns out of overcrowded hospitals, while getting them the comprehensive out-patient care that they need, faster. Across Canada, hospitals are facing unprecedented strain. Since 2019, emergency departments have experienced more than 1.14 million hours of closure , the equivalent of 47,500 lost days of emergency care. Ontario and Alberta have been hit especially hard, with rural ER closures and care disruptions becoming a regular occurrence. This reality has left communities with few options and patients in critical need of safe, timely alternatives. British Columbia is equally seeing regular ER closures throughout 2025, causing challenges for patients, healthcare systems and especially rural communities: BC is not Alone – Rural ER Crisis across Canada – BC Rural Health Network While in many cases a virtual-only system is not a replacement for in-person emergency care, Rocket Doctor's ED diversion program is helping to support hospitals and patients to fill a void in accessible care. The platform enables hospital systems to allow patients to self-select to reroute themselves to clinically appropriate, out-patient consultations, leveraging customized intake forms, real-time triage, and a flexible physician network, either from independent MDs on Rocket Doctor's platform, or the hospital's own staff. At Georgian Bay General Hospital in Ontario, the results speak for themselves. Between June 2022 and December 2024, more than 3,065 patients have been successfully managed through MDs on Rocket Doctor's platform, with 97% of patients treated virtually and only 1% redirected to the ER. Patients waited an average of just 20 minutes to connect with a physician. The estimated system savings totaled $1.4 million, based on an average $475 cost per diverted ER visit multiplied by the total number of patients seen. All visits were covered under OHIP, with no additional fees to patients. In Alberta, Rocket Doctor has seen similar success across its broader platform, with over 12,000 patients seen in the past 3 months alone, entirely funded by provincial health insurance. More than 98% of these visits were resolved without requiring in-person care, and less than 1% were sent to the ER. 'We see so many patients in our rural, remote and even urban communities going to ED, often when they recognize that they could be seen outside the hospital.' Said Dr. William Cherniak, CEO of Rocket Doctor. 'There has been a lot of good content from the Canadian Association of Emergency Physicians (CAEP) to recognize that we need to support patients to access healthcare where they see most appropriate. We often see patients choose an ED with low-acuity issues simply because of a lack of access to family doctors, or other accessible out-patient choices.' By leveraging smart triage and other digital tools, Rocket Doctor's ED Diversion Program and broader platform pairs patients with the right physician based on their needs, empowering physicians to order labs, imaging, make specialist referrals, or escalate care to in-person options when clinically necessary (although rare). Patients can also rebook with the same physician to ensure continuity of care, improving outcomes and reducing unnecessary visits. 'We are filling that gap by empowering physicians in a team-based cloud-enabled model of care with technological support to work at the top of their license within their clinical competencies digitally.' said Dr. Cherniak. 'We're building a system that gives patients a smarter entry point and gives physicians the tools to work independently, safely, and efficiently.' As staffing shortages and rural hospital disruptions continue to affect patients across Canada, Rocket Doctor and AI are offering hospitals and provincial systems a deployable, proven solution; one that reduces backlog, lowers system strain, and drives meaningful outcomes at scale. About AI Inc. AI is a company utilizing AI (artificial intelligence) and best clinical practices to positively improve the healthcare sector and impact current inefficiencies and challenges. With the input of hundreds of healthcare professionals globally, AI has built a comprehensive, personalized healthcare AI engine - the Global Library of Medicine (GLM). With more than 10,000 expert medical reviews, the GLM delivers tested clinical information and support to all healthcare professionals as well as providing recommended tests (physical and lab), imaging and billing codes. The GLM helps healthcare professionals (doctors, nurses or pharmacists) reduce their administrative burden; creates more time for needed face-to-face patient appointments; and enables greater consistency in quality of patient support. AI's GLM platform, through supporting healthcare professionals, allows for the inclusion of disenfranchised communities. Learn more at or contact info@ . About Rocket Doctor Inc. Rocket Doctor is a technology-driven digital health platform and marketplace that is breaking down obstacles that limit access to quality, comprehensive and cost-effective healthcare. Our proprietary software equips doctors with the tools to run practices in virtual and hybridized in-person/virtual models of care, enabling them to provide tailored care to patients in rural and Northern communities across Canada and on Medicaid in the United States. Leveraging large language models, AI/ML and wireless medical devices, Rocket Doctor is bridging the healthcare divide, connecting patients to equitable and accessible virtual healthcare services regardless of age, location, or financial status. To learn more about Rocket Doctor's platform and services, visit (Canada) or (U.S.), or contact media@ . FOR ADDITIONAL INFORMATION, CONTACT: Dr. Essam Hamza, CEO, AI Email: ehamza@ Call: +1 (612) 788-8900 / Toll-Free USA/Canada: +1 (888) 788-8955 Dr. Bill Cherniak, CEO, Rocket Doctor Email: bill@ Media inquiries: media@ Cautionary Statement This news release contains forward-looking statements that are based on AI's expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the implementation of its shareholder communications initiative and the timing thereof. Although believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements, and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law. The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.


Hamilton Spectator
5 hours ago
- Hamilton Spectator
Medicenna Strengthens Intellectual Property Portfolio with Five Patents Granted for its IL-2 and IL-4 Superkines
TORONTO and HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) — Medicenna Therapeutics Corp. ('Medicenna' or the 'Company') (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing novel Superkines for oncology and autoimmune diseases, today announced grant of five patents covering the Company's IL-2 and IL-4 Superkine platforms. These patents strengthen Medicenna's intellectual property (IP) position across key markets and further support the Company's lead clinical and preclinical programs. The newly granted patents cover composition, formulation, combination, use, and therapeutic applications of IL-2 and IL-4 Superkines. Newly granted patents span major markets, with anticipated expiration dates ranging from 2033 to 2040 depending on the specific case and local rules, without accounting for any potential extensions. Patents granted include: 'These newly granted and allowed patents not only expand the breadth and depth of our intellectual property portfolio but also enhance the long-term commercial potential of our Superkine programs,' said Fahar Merchant, Ph.D., President and CEO of Medicenna. 'Notably, the patent covering IL-2 superagonists in combination with anti-PD1 antibodies provides important coverage for MDNA11, which is being evaluated in the ongoing Phase 1/2 ABILITY-1 study, reinforcing both the clinical rationale and commercial potential. Furthermore, protection granted to a novel formulation of bizaxofusp (MDNA55), used in the Phase 2b recurrent glioblastoma clinical trial, solidifies its commercial exclusivity for treatment of brain cancers as we pursue potential partnering of this Phase 3 ready asset. By strengthening long-term protection for our proprietary IL-2 and IL-4 assets across key jurisdictions, we are laying the foundation for durable competitive advantage and sustained shareholder value. We look forward to sharing additional clinical data from the ABILITY-1 clinical trial during the balance of this calendar year.' Medicenna's global IP portfolio now comprises 86 granted or allowed patents, supporting a robust and diverse clinical pipeline. About Medicenna Therapeutics Medicenna is a clinical-stage immunotherapy company focused on developing novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines and first-in-class Empowered Superkines. Medicenna's long-acting IL-2 Superkine, MDNA11, is a next-generation IL-2 with superior affinity toward CD122 (IL-2 receptor beta) and no CD25 (IL-2 receptor alpha) binding, thereby preferentially stimulating cancer-killing effector T cells and NK cells. Medicenna's IL-4 Empowered Superkine, bizaxofusp (formerly MDNA55), has been studied in 5 clinical trials enrolling over 130 patients, including a Phase 2b trial for recurrent GBM, the most common and uniformly fatal form of brain cancer. Bizaxofusp has obtained FastTrack and Orphan Drug status from the FDA and FDA/EMA, respectively. Medicenna's early-stage high-affinity IL-2β biased IL-2/IL-15 Super-antagonists, from its MDNA209 platform, are being evaluated as potential therapies for autoimmune and graft-versus host diseases. Medicenna's early-stage BiSKITs™ (Bifunctional SuperKine ImmunoTherapies) and the T-MASK™ (Targeted Metalloprotease Activated SuperKine) programs are designed to enhance the ability of Superkines to treat immunologically 'cold' tumors. For more information, please visit , and follow us on X and LinkedIn . Forward-Looking Statements This news release contains forward-looking statements within the meaning of applicable securities laws. Forward-looking statements include, but are not limited to, express or implied statements regarding the future operations of the Company, estimates, plans, strategic ambitions, partnership activities and opportunities, objectives, expectations, opinions, forecasts, projections, guidance, outlook, intellectual property protection, clinical and commercial potential, competitive position and shareholder value creation or or other statements that are not historical facts. Drug development and commercialization involve a high degree of risk, and only a small number of research and development programs result in commercialization of a product. Results in early-stage pre-clinical or clinical studies may not be indicative of full results or results from later stage or larger scale clinical studies and do not ensure regulatory approval. You should not place undue reliance on these statements, or the scientific data presented. Forward-looking statements are often identified by terms such as 'will', 'may', 'should', 'anticipate', 'expect', 'believe', 'seek', 'potentially' and similar expressions. and are subject to risks and uncertainties. There can be no assurance that such statements will prove to be accurate and actual results and future events could differ materially from those anticipated in such statements. Important factors that could cause actual results to differ materially from the Company's expectations include the risks detailed in the latest annual information form of the Company and in other filings made by the Company with the applicable securities regulators from time to time in Canada. The reader is cautioned that assumptions used in the preparation of any forward-looking information may prove to be incorrect. Events or circumstances may cause actual results to differ materially from those predicted, as a result of numerous known and unknown risks, uncertainties, and other factors, many of which are beyond the control of the Company. The reader is cautioned not to place undue reliance on any forward-looking information. Such information, although considered reasonable by management, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this news release are expressly qualified by this cautionary statement. The forward-looking statements contained in this news release are made as of the date hereof and except as required by law, we do not intend and do not assume any obligation to update or revise publicly any of the included forward-looking statements. This news release contains hyperlinks to information that is not deemed to be incorporated by reference in this new release. Investor/Media Contact: Shushu Feng Investor Relations, Medicenna Therapeutics ir@